[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100558639":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":20,"responsibleParty":32,"collaborators":7,"id":34,"slug":7,"hasResults":35,"nctId":36,"briefTitle":37,"officialTitle":38,"acronym":7,"eligibilityCriteria":39,"healthyVolunteers":35,"sex":40,"minAge":41,"maxAge":7,"enrollmentInfo":42,"targetDuration":7,"studyType":45,"phases":7,"briefSummary":46,"conditions":47,"keywords":7,"overallStatus":51,"whyStopped":7,"lastUpdateSubmitDate":52,"lastUpdatePostDateStruct":53,"startDateStruct":56,"completionDateStruct":58,"leadSponsor":60,"locationsCount":61},{"fullName":5,"class":6},"European Institute of Oncology","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"Giuseppe Testa","PRINCIPAL_INVESTIGATOR",[13,17],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":16},"CONTACT","+39 02 9437 5105","giuseppe.testa@ieo.it",{"name":18,"role":14,"phone":7,"phoneExt":7,"email":19},"Pietro Lo Riso","pietro.loriso@ieo.it",[21],{"facility":5,"status":7,"city":22,"state":7,"zip":7,"country":23,"cosmosGeoPoint":24,"geoPoint":29,"contacts":30},"Milan","Italy",{"type":25,"coordinates":26},"Point",[27,28],9.18951,45.46427,{"lat":28,"lon":27},[31],{"name":10,"role":14,"phone":7,"phoneExt":7,"email":7},{"type":33,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100558639",false,"NCT06553742","High Definition Profiling of Ovarian Cancer Ascites","High Definition Profiling of Ovarian Cancer Ascites for the Identification of Prognostic Biomarkers and Immunotherapeutic Targets: an Integrative Cell of Origin-guided Approach","Inclusion Criteria:\n\n* Patients with suspicious or confirmed ovarian cancer pathology undergoing debulking surgery\n* Diagnosis of high grade serous ovarian cancer confirmed by histopathology assessment\n* Patients who provided written informed consent\n\nExclusion Criteria:\n\n* HIV-positive patients\n* HBV-positive patients\n* HCV-positive patients","FEMALE","18 Years",{"count":43,"type":44},50,"ESTIMATED","OBSERVATIONAL","This project entails the collection of a prospective cohort of ascites (AS) samples from High Grade Serous Ovarian Cancer (HGSOC) patients.\n\nHigh Grade Serous Ovarian Cancer (HGSOC) is a major cause of cancer-related mortality, due to the late-stage diagnosis and failure of surgery and chemotherapy (CHT) to eradicate the disease with no significant improvement in overall survival.\n\nThe primary objective of the project is to generate a comprehensive map of ascites cell components, detailing both their intrinsic features and the landscape of cellular interactions mediated by soluble factors in ascitic fluid.",[48,49,50],"Ovarian Cancer","High Grade Ovarian Serous Adenocarcinoma","Ascites","NOT_YET_RECRUITING","2024-11-18",{"date":54,"type":55},"2024-11-20","ACTUAL",{"date":57,"type":44},"2024-11",{"date":59,"type":44},"2033-12",{"name":5,"class":6},1]